In a transition that will take effect on March 1, 2016, James Bradner, associate professor of medicine at Brigham and Women’s Hospital and Dana Farber Cancer Institute, will take over as president of the Cambridge-based Novartis Institutes for BioMedical Research.
Trending News
Rare Inherited Genetic Mutation Is One of Strongest Indicators Yet for Lung Cancer Risk
Influence of EGFR variant could expand screening guidelines
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease